Journal for ImmunoTherapy of Cancer (Nov 2020)

796 A phase I/II trial combining avelumab and trabectedin for advanced liposarcoma and leiomyosarcoma

  • Michael Wagner,
  • Lee Cranmer,
  • Seth Pollack,
  • Qianchuan He,
  • Yuzheng Zhang,
  • Elizabeth Loggers,
  • Sabrina McDonnell,
  • Shannon Maxwell

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0796
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.